Health Research Institute

The mutable landscape of health policy, technology, and operations demands that industry professionals stay on top of key trends. PricewaterhouseCoopers' Health Research Institute focuses on large scale issues and major developments and includes analysis on healthcare trends as well as key insights and industry best practices.

Areas of research and analysis include trends and challenges facing:
  • Healthcare providers, including hospitals, health systems and physician practices.
  • Payers, including commercial health plans and companies and public governmental insurers.
  • Employers - corporations from all industries concerned about the coverage and costs of healthcare provided to their employees.
  • Pharmaceutical companies, including pharmaceutical manufacturers, suppliers, researchers, benefits managers and distributors.
  • Life sciences companies, including medical research, biotechnology and medical device organizations.




The Price of Excess: Identifying Waste in Healthcare Spending
More than half of the $2.2 trillion spent annually on healthcare in the U.S. could be considered wasteful, according to an analysis published by PricewaterhouseCoopers’ Health Research Institute. Defensive medicine, such as redundant, inappropriate or unnecessary tests and procedures, was identified as the biggest area of excess, followed by inefficient healthcare administration and the cost of care necessitated by conditions such as obesity, which can be considered preventable by lifestyle changes. See more

Paying for Performance: Incentives and the English Health System
Many countries are looking at ways to reform their healthcare payment systems around performance. The English system for paying primary care physicians is the only one in the world that bases a significant portion of physicians’ pay on quality metrics. For that reason, this “pay for performance” (P4P) system is worthy of study, and the PricewaterhouseCoopers Health Research Institute (HRI) report shows what is working well, what needs further refinement and what should be considered when implementing pay for performance methodologies. The learnings from this go far beyond the English system. See more

Research rewired: Merging care and research information to improve knowledge discovery
Today's ad hoc methods of managing research information are beginning to strain under increasing demands for new drugs, more personalized medicine, better diagnostic tools, and post-market safety monitoring. This report investigates the benefits, barriers, and emerging approaches to creating an integrated information environment that will help to shape scientific diagnostic, drug, and device discovery in the future. See more

Top Eight Health Industry Issues in 2008
Health organizations face a pivotal year in 2008 as they anticipate the wildcard outcome of the presidential election. Meanwhile, they must prepare for impending changes — pharmaceutical and life sciences companies are adapting to a new safety agenda from the FDA including the agency’s expanded authority over post-market drug safety. See more

See descriptions of our currently available publications


Contacts
David Chin, MD
Health Research Institute leader
Tel: +1 (617) 530 4381
Sandy Lutz
Health Research Institute managing director
Tel: +1 (214) 754 5434
Benjamin Isgur
Health Research Institute assistant director
Tel: +1 (214) 754 5091

© 2007-2008 PricewaterhouseCoopers. All rights reserved. PricewaterhouseCoopers refers to the network of member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.
Accessibility information Skip navigation Countries online